Interdisciplinary research teams who seek to answer compelling questions in the area of translational research can pitch their ideas through the MCubed Diamond Program. MICHR will fully fund a variety of classic cubes ($60K) and mini cubes ($15K). In the absence of traditional funding agency peer review, awarded teams will be able to pursue their innovative ideas and collaborative efforts quickly. Pitches will be accepted through May 15, 2019.
Join MICHR for an interactive workshop presenting the basics of budgeting for research grants. Learn how to calculate indirect costs, determine calendar months for effort, complete other budget components, and write a budget justification. We will also talk about how to monitor expenses after you are awarded and the closeout (FFR) process. This budgeting workshop is modeled using a NIH budget format.
Staff from MICHR recently published a paper highlighting the impact of a mentor recognition program. The paper, published in the Journal of Clinical and Translational Science, discusses the creation of MICHR’s Distinguished Clinical & Translational Research Mentor Award and its impact on the culture of mentorship at U-M.
Applications are now being accepted for the two-year MICHR-K Award. The award provides protected time for a clinician scientist to focus on conducting clinical research. Early career faculty with an MD or clinical PhD who are interested in obtaining mentored training in translational sciences are encouraged to apply.
Deadline extended to March 18! Have you and your research benefited from the support of a mentor? Does your mentor have a track record of successfully mentoring students, fellows, or early career faculty at the University of Michigan? Consider nominating your mentor for the 2019 Distinguished Clinical & Translational Research Mentor Award.
Are you interested in research that addresses community health in Flint? Apply now for a funding opportunity that funds community-engaged research partnerships and projects addressing community priorities in Flint.
Applicants may request up to $5,000 for partnership development activities or up to $10,000 for conducting small-scale research projects.
A patient’s journey from Arizona to the U-M Rogel Cancer Center to participate in clinical research led to the successful removal of her cancerous tumor. The trial involved adding an oral agent known as AZD 1775 to chemotherapy and radiation. In laboratory studies, it did a better job killing pancreatic cancer cells.
George Mashour, MD, PhD, an expert in anesthesiology and neuroscience, is among the new members of the National Academy of Medicine of the National Academies, one of the highest honors in the fields of health and medicine. Dr. Mashour was elected to the NAM in recognition of major contributions to the advancement of the medical sciences, health care and public health. U-M now has 58 members of the NAM on its active and emeritus faculty.
To address the need for consistent training, assessment, and measures of competency, MICHR has collaborated with three universities to launch the DIAMOND portal.
The portal is a pioneering digital collection that serves as a database for members of clinical and translational research study teams to share and access training and assessment resources.
MICHR is seeking a program lead for mentoring initiatives to assist the faculty director and the administrative program director with the development and review of mentoring and career development programs and initiatives for faculty, scholars, and trainees both across EMG programs and across the university. Applications are due November 15.
To support faculty along their career trajectories, MICHR is offering two new funding mechanisms intended to support investigators who need to collect additional data to competitively pursue their first extramural grants (such as NIH K or R21) or larger independent grants (such as NIH R01 or similar).
Between 50 to 60 percent of patients who receive donated bone marrow or stem cells develop a major complication called graft-versus-host disease, with a mortality rate of 75 to 100 percent among those with the most severe cases of the disease.
That’s why Sung Won Choi, MD, MS has devoted the past decade of her career to research intended not only to better treat GVHD but also to prevent it from occurring in the first place.
Experts from across the University of Michigan and beyond presented and discussed issues related to LGBTQ+ communities on September 6. The first-ever LGBTQ Inclusion as Researchers & in Research Symposium was attended by faculty, staff, students, and visiting alumni.
Hosted by the U-M LGBT Faculty Alliance, Spectrum Center, and Rackham Graduate School and sponsored by MICHR, the day-long event focused on unmet health care needs and better integration of LGBTQ communities at U-M.